Alembic Pharma gets five observations from USFDA for Gujarat facility

As per the USFDA, a Form 483 is issued to a firm's management at the conclusion of an inspection when an investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39VIZST
via IFTTT